![]() ![]() One patient had insufficient data regarding receipt of a crossover treatment. Six patients (including the 4 patients who withdrew) did not receive a crossover treatment. One patient had insufficient data regarding receipt of HFNO or a crossover treatment (lost to follow-up).įAll 7 patients received treatment. One patient withdrew and did not receive CPAP or a crossover treatment.ĮThe 2 patients who withdrew did not receive HFNO or a crossover treatment. These patients were excluded from the analyses.ĬThere were 114 patients randomized to continuous positive airway pressure (CPAP) and 103 patients randomized to conventional oxygen therapy when high-flow nasal oxygen (HFNO) was not available 109 patients randomized to HFNO and 113 to conventional oxygen therapy when CPAP was not available and 266 patients randomized to CPAP, 309 to HFNO, and 259 to conventional oxygen therapy when all therapies were available.ĭTwo patients did not receive adequate treatment information or a crossover treatment (1 withdrew and 1 lost to follow-up). ![]() RECOVERY-RS indicates Randomized Evaluation of COVID-19 Therapy–Respiratory Support.ĪGiven the COVID-19 pandemic circumstances, investigators did not have hospitals track everyone who was approached or considered but not randomized.īFive patients were mistakenly randomized twice (3 to the conventional oxygen therapy group and 2 to the high-flow nasal oxygen group), but did not receive treatment. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |